| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5594289 | American Heart Journal | 2017 | 9 Pages |
Abstract
Among new-onset AF patients, non-vitamin K antagonist oral anticoagulant use has increased and antiplatelet monotherapy has decreased. However, anticoagulation is used frequently in low-risk patients and inconsistently in those at high risk of stroke. Significant geographic variability in anticoagulation persists and represents an opportunity for improvement.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Benjamin A. MD, MHS, Haiyan PhD, Peter MA, Karen MS, Laine PhD, A. John MD, Michael D. MB, ChB, DPhil, Gregg C. MD, Bernard J. MB, ChB, DPhil, Samuel MD, Sylvia MD, Werner MD, PhD, Peter R. MD, Jack MD, Kenneth W. MD, Gerald MD, James A. MD,